Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP86460.RA_ydn9qD9oiFJwCYxUx_nTOU-QUYVm5XYkHxrysovq5M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP86460.RA_ydn9qD9oiFJwCYxUx_nTOU-QUYVm5XYkHxrysovq5M130_assertion type Assertion NP86460.RA_ydn9qD9oiFJwCYxUx_nTOU-QUYVm5XYkHxrysovq5M130_head.
- NP86460.RA_ydn9qD9oiFJwCYxUx_nTOU-QUYVm5XYkHxrysovq5M130_assertion description "[In this study, associations between IM trough concentration, clinical response and 11 single-nucleotide polymorphisms in genes involved in IM pharmacokinetics (ABCB1, ABCC2, ABCG2 CYP3A5, SLC22A1 and SLCO1B3) were investigated among 67 Japanese chronic phase CML patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP86460.RA_ydn9qD9oiFJwCYxUx_nTOU-QUYVm5XYkHxrysovq5M130_provenance.
- NP86460.RA_ydn9qD9oiFJwCYxUx_nTOU-QUYVm5XYkHxrysovq5M130_assertion evidence source_evidence_literature NP86460.RA_ydn9qD9oiFJwCYxUx_nTOU-QUYVm5XYkHxrysovq5M130_provenance.
- NP86460.RA_ydn9qD9oiFJwCYxUx_nTOU-QUYVm5XYkHxrysovq5M130_assertion SIO_000772 20720558 NP86460.RA_ydn9qD9oiFJwCYxUx_nTOU-QUYVm5XYkHxrysovq5M130_provenance.
- NP86460.RA_ydn9qD9oiFJwCYxUx_nTOU-QUYVm5XYkHxrysovq5M130_assertion wasDerivedFrom gad-20130706 NP86460.RA_ydn9qD9oiFJwCYxUx_nTOU-QUYVm5XYkHxrysovq5M130_provenance.
- NP86460.RA_ydn9qD9oiFJwCYxUx_nTOU-QUYVm5XYkHxrysovq5M130_assertion wasGeneratedBy ECO_0000203 NP86460.RA_ydn9qD9oiFJwCYxUx_nTOU-QUYVm5XYkHxrysovq5M130_provenance.